Search Results - "CASAVILLA, A"

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study by Marsh, J W, Dvorchik, I, Subotin, M, Balan, V, Rakela, J, Popechitelev, E P, Subbotin, V, Casavilla, A, Carr, B I, Fung, J J, Iwatsuki, S

“…Orthotopic liver transplantation (OLTx) in the presence of hepatocellular carcinoma (HCC) has been complicated by high recurrence rates. The ability to…”
Get full text

Hepatic resection and transplantation for peripheral cholangiocarcinoma by CASAVILLA, F. A, MARSH, J. W, IWATSUKI, S, TODO, S, LEE, R. G, MADARIAGA, J. R, PINNA, A, DVORCHIK, I, FUNG, J. J, STARZL, T. E

“…Recent publications have questioned the role of orthotopic liver transplantation (OLT) in treating advanced or unresectable peripheral cholangiocarcinoma…”
Get full text

The influence of hepatitis C virus genotypes on the outcome of liver transplantation by Vargas, Hugo E., Laskus, Tomasz, Wang, Lian‐Fu, Radkowski, Marek, Poutous, Anthony, Lee, Randall, Demetris, J. Anthony, Gayowski, Timothy, Marino, Ignazio R., Singh, Nina, Dodson, Forest, Casavilla, Adrian, Fung, John J., Rakela, Jorge

“…Background: The aim of this study was to report the influence of hepatitis C virus (HCV) genotypes and HLA matches on the outcome of liver transplantation,…”
Get full text

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine by Fung, J, Abu-Elmagd, K, Jain, A, Gordon, R, Tzakis, A, Todo, S, Takaya, S, Alessiani, M, Demetris, A, Bronster, O

Get more information

Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience by Casavilla, A, Ramirez, C, Shapiro, R, Nghiem, D, Miracle, K, Fung, J J, Starzl, T E

Get more information

Experience with liver and kidney allografts from non-heart-beating donors by Casavilla, A, Ramirez, C, Shapiro, R, Nghiem, D, Miracle, K, Fung, J J, Starzl, T E

Get more information

Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation by Amesur, N B, Zajko, A B, Orons, P D, Sammon, J K, Casavilla, F A

“…Transjugular intrahepatic portosystemic shunt (TIPS) placement is an accepted treatment for refractory variceal bleeding and/or ascites in end-stage liver…”
Get more information

Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus by Casavilla, F. Adrian, Rakela, Jorge, Kapur, Sandip, Irish, William, McMichael, John, Demetris, Anthony J., Starzl, Thomas E., Fung, John J.

“…The outcome of hepatitis C virus (HCV) infection on patient and graft survival after orthotopic liver transplantation (OLT) has been controversial. An earlier…”
Get full text

Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma by Marsh, J W, Casavilla, A, Iwatsuki, S, Dvorchik, I, Subotin, M, Balan, V, Rakela, J, Subbotin, V, Popechitelev, E P

Get full text

Clinical course after liver transplantation in patients with sarcoidosis by CASAVILLA, F. A, GORDON, R, WRIGHT, H. I, GAVALER, J. S, STARZL, T. E, VAN THIEL, D. H

Get full text

Distribution of Infecting Hepatitis C Virus Genotypes in End-Stage Liver Disease Patients at a Large American Transplantation Center by Vargas, Hugo E., Wang, Lian-Fu, Laskus, Tomasz, Poutous, Anthony, Lee, Randall, Demetris, Anthony, Dodson, Forrest, Casavilla, Adrian, Fung, John, Gayowski, Timothy, Singh, Nina, Marino, Ignazio, Rakela, Jorge

“…The distribution of hepatitis C virus (HCV) genotypes was studied in 202 anti-HCV-positive liver transplant candidates with end-stage liver disease. HCV…”
Get full text

Advantages of the rapid en bloc technique for pancreas/liver recovery by Dodson, F, Pinna, A, Jabbour, N, Casavilla, A, Khan, F, Corry, R

Get more information

Cadaveric liver donors; what are the limits? by Casavilla, A, Mazariegos, G, Fung, J J

“…The current crisis in organ availability will only be solved by aggressive and innovative solutions. One approach, outlined here, is to more carefully assess…”
Get more information

Should Reimbursement Be Denied for Liver Transplantation in Patients With Hepatocellular Carcinoma? by Marsh, J. Wallis, Dvorchik, Igor, Casavilla, Adrian, Fung, John J, Iwatsuki, Shunzaboro

“…To the Editor.—On July 15, 1996, the US Department of Health and Human Services expanded financial coverage of liver transplantation to all end-stage liver…”
Get full text

One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events by Jain, A B, Fung, J J, Todo, S, Reyes, J, Selby, R, Irish, W, Doyle, H, Abu-Elmagd, K, Casavilla, A, Nour, B

Get more information

Orthotopic liver transplantation in dogs receiving FK-506 by Todo, S, Podesta, L, ChapChap, P, Kahn, D, Pan, C E, Ueda, Y, Okuda, K, Imventarza, O, Casavilla, A, Demetris, A J

“…Ten dogs that survived the perioperative events of liver transplantation were treated with 1 mg/kg/d oral FK. Eight of the recipients lived for at least 1…”
Get more information

Donor selection and surgical technique for en bloc liver-small bowel graft procurement by Casavilla, A, Selby, R, Abu-Elmagd, K, Tzakis, A, Todo, S, Starzl, T E

Get more information

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids by Todo, S, Demetris, A J, Ueda, Y, Imventarza, O, Okuda, K, Casavilla, A, Cemaj, S, Ghalab, A, Mazzaferro, V, Rhoe, B S

“…The immunosuppressive agent FK permitted increased kidney transplant survival in dogs over a wide dose range, but with weight loss and manifold evidence of…”
Get more information

Nutritional management of intestinal transplant recipients by Reyes, J, Tzakis, A G, Todo, S, Nour, B, Casavilla, A, Abu-Elmagd, K, Fung, J J, Starzl, T E

Get more information

Intestinal transplantation in humans under FK 506 by Todo, S, Tzakis, A, Reyes, J, Abu-Elmagd, K, Casavilla, A, Fung, J J, Starzl, T E

Get more information